Back to UBS Group AG UBS Group AG

INABINAB
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in IN8BIO INC

Yes. Ubs holds 1 shares of INAB (IN8BIO), worth $1, as of its Q2 2026 13F filing. It reduced the position by 479 shares (-99.8%) from Q1 2026. Ubs has held INAB since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1

Current Shares

1

Total Value Change

-$1,000

Total Shares Change

-478

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1
-99.8%
$10.0%$1.41
0
2026-Q1
Decreased
480
-38.2%
$7100.0%$1.48
0
2025-Q4
Increased
777
+5080.0%
$1,8180.0%$2.34
12
2025-Q3
Decreased
15
-96.9%
$320.0%$2.17
0
2025-Q2
New
479
-
$1,0010.0%$2.09
17

Other major holders of INAB: Alyeska Investment Group, L.P., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used